Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neurology

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.47.4.1015PMID 8857738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy

  1995cited by this paper
• SPECT in the localisation of extratemporal and temporal seizure foci.

  1995cited by this paper
• Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.

  1995cited by this paper
• National Family Health Survey: summary of basic findings.

  1995cited by this paper
• Ictal postictal and interictal single-photon emission tomography in the lateralization of temporal lobe epilepsy

  1994cited by this paper
• Hippocampal sclerosis without detectable hippocampal atrophy

  1994cited by this paper
• Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion

  1994cited by this paper
• Medical records and the IT revolution.

  1994cited by this paper
• Intractable nonlesional epilepsy of temporal lobe origin

  1994cited by this paper
• The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy

  1994cited by this paper
• Comparison of benzodiazepine receptor and regional cerebral blood flow imaging of epileptiform foci in hippocampal kindled rabbits: a preliminary report.

  1994cited by this paper
• Lack of effect of concomitant clobazam on interictal 123I-iomazenil SPECT.

  1993cited by this paper
• Optimizing the diagnosis of hippocampal sclerosis using MR imaging.

  1993cited by this paper
• Outcome with respect to epileptic seizures.

  1993cited by this paper
• Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I‐iododexetimide and single‐photon emission computed tomography in epilepsy

  1993cited by this paper
• Neurosurgical horizons in Parkinson's disease

  1993cited by this paper
• MRI hippocampal volumes and memory function before and after temporal lobectomy

  1993cited by this paper
• Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures

  1992cited by this paper
• Postictal switch in blood flow distribution and temporal lobe seizures.

  1992cited by this paper
• Imaging Muscarinic Cholinergic Receptors in Human Brain in vivo with SPECT, [123I]4-Iododexetimide, and [123I]4-Iodolevetimide

  1992cited by this paper
• Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy.

  1992cited by this paper
• Anti-GM1 antibodies in patients with Guillain-Barré syndrome.

  1992cited by this paper
• Two types of epileptic foci generating brief and sustained paroxysms in the in vitro rat hippocampus.

  1992cited by this paper
• Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO.

  1992cited by this paper
• Neuronal activity related to faces and matching in human right nondominant temporal cortex.

  1992cited by this paper
• Socializing nursing students into professional activities.

  1992cited by this paper
• Prevalence of Epilepsy in Rochester, Minnesota: 1940–1980

  1991cited by this paper
• In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide.

  1991cited by this paper
• Maternal and paternal alcohol use: effects on the immune system of the offspring.

  1991cited by this paper
• Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography

  1991cited by this paper
• The Lewy body variant of Alzheimer's disease

  1990cited by this paper
• Hippocampal sclerosis can be reliably detected by magnetic resonance imaging

  1990cited by this paper
• Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.

  1989cited by this paper
• Medicinal chemistry: 1989 and beyond.

  1989cited by this paper
• Basic mechanisms of the epilepsies : molecular and cellular approaches

  1986cited by this paper
• New wave of research in the epilepsies.

  1986cited by this paper
• Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer.

  1985cited by this paper
• Summation of the workshops and discussion: The new wave of research in the epilepsies

  1984cited by this paper
• Amygdala kindling induces muscarinic cholinergic receptor declines in a highly specific distribution within the limbic system.

  1980cited by this paper
• Muscarinic cholinergic regulation of epileptic spiking in kindling.

  1979cited by this paper
• STEREOSPECIFIC IN VlTRO BINDING OF [3H]DEXETIMIDE TO BRAIN MUSCARINIC RECEPTORS

  1979cited by this paper
• Muscarinic cholinergic receptors participate in the kindling model of epilepsy.

  1978cited by this paper
• Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

  1977cited by this paper

• PET y SPECT de neurotransmisión cerebral PET and SPECT of cerebral neurotransmission

  2016cites this paper
• 18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy

  2016cites this paper
• Human Brain Imaging of Acetylcholine Receptors

  2014cites this paper
• The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.

  2012cites this paper
• Acetylcholine and posttraumatic stress disorder.

  2009cites this paper
• Specific Issues Related to EEG-fMRI at B 0 > 3 T

  2009cites this paper
• Antiepileptic drugs and muscarinic receptor-dependent excitation in the rat subiculum.

  2007cites this paper
• Imaging of muscarinic receptors in the central nervous system.

  2006cites this paper
• A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery.

  2006cites this paper
• Zur pathophysiologischen Bedeutung der Amygdala in der Affektregulation bei psychischen Störungen

  2005cites this paper
• Quantitative Functional Imaging with Positron Emission Tomography: Principles and Instrumentation

  2005cites this paper
• CHAPTER 14 – Single-photon-emission Computed Tomography in Epilepsy

  2005cites this paper
• Sequential 123I-iododexetimide scans in temporal lobe epilepsy: comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging)

  2005cites this paper
• PET y SPECT de neurotransmisión cerebral

  2003cites this paper
• Evaluation of Opioid Peptide and Muscarinic Receptors in Human Epileptogenic Neocortex: An Autoradiography Study

  2002cites this paper
• Positron emission tomography and epilepsy.

  2002cites this paper
• Targeting Cerebral Muscarinic Acetylcholine Receptors with Radioligands for Diagnostic Nuclear Medicine Studies

  2001cites this paper
• Stereoselective synthesis, in vitro, and initial in vivo evaluation of 1-methylpiperidin-4-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IPIP): a novel radioiodinated molecular probe with high affinity for the muscarinic receptor.

  2001cites this paper
• SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP

  2001cites this paper
• Stereoselective synthesis, in vitro, and initial in vivo evaluation of 1-methylpiperidin-4-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate (IPIP): a novel radioiodinated molecular probe with high affinity for the muscarinic receptor

  2001cites this paper
• SPECT in neocortical epilepsies.

  2000cites this paper
• In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.

  1999cites this paper
• Muscarinic Receptor Loss and Preservation of Presynaptic Cholinergic Terminals in Hippocampal Sclerosis

  1999cites this paper
• Neuropharmacological imaging in epilepsy with PET and SPECT.

  1998cites this paper
• SPECT and Behavior

  1997cites this paper
• Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy

  1997cites this paper